- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 12, 2025 | 120.79M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 56.16M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 25.38M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 6.93M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 6.79M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $1.81M |
| Capex | Q3 2025 · Sep 30, 2024 | $1.69M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$11.25M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$4.69M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $44.55M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $877K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $3.84M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $4.85M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$21.58M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$16.6M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$15.65M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$9.4M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$297K |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $5.27M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $17.81M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $27.91M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $25.68M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $21.86M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $95.42M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $84.62M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $34.51M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $32.93M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $73.84M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $75.21M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.20 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.98 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.98 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$4.53 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.20 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.98 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.98 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$4.53 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $5.3M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $16.28M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $4.36M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $14.88M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $585K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $2.28M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $1.63M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $4.5M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$11.07M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$24.9M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$7.03M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$6.8M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$6.78M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$30.77M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$13.63M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$10.37M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$3.78M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$12.97M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$6.03M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$18.61M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $4.74M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $13.27M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $2.87M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $9.09M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $11.23M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $32.3M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $9.85M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $29.35M |
| Revenue | Q3 2025 · Sep 30, 2025 | $15.97M |
| Revenue | Q3 2025 · Sep 30, 2025 | $45.57M |
| Revenue | Q3 2025 · Sep 30, 2024 | $12.72M |
| Revenue | Q3 2025 · Sep 30, 2024 | $38.43M |